The Discounted Cash Flow (DCF) valuation of Jazz Pharmaceuticals PLC (JAZZ) is (187.02) USD. With the latest stock price at 218.42 USD, the upside of Jazz Pharmaceuticals PLC based on DCF is -185.6%.
Based on the latest price of 218.42 USD and our DCF valuation, Jazz Pharmaceuticals PLC (JAZZ) is a sell. selling JAZZ stocks now will result in a potential gain of 185.6%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.7% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.5% | 3.8% |
| Fair Price | (1,135.27) - (123.06) | (187.02) |
| Upside | -619.8% - -156.3% | -185.6% |